Original news and analysis on international IP policy
By Tatum Anderson for Intellectual Property Watch The Indian government will consider whether it should grant permission for patented drugs to be manufactured and exported without the consent of the patent owners at a hearing scheduled for the last week…
By Tatum Anderson for Intellectual Property Watch
A German court has thrown out a case involving patents brought by Finnish phone manufacturer Nokia against US chipmaker Qualcomm. The case is one of several internationally between the two companies that could have an impact on telecommunications and information access.
By Tatum Anderson for Intellectual Property Watch NAIROBI – One of Kenya’s most prestigious research institutions, Kenya Medical Research Institute (KEMRI), has begun an extensive intellectual property audit to try and identify any discoveries that should be protected. The audit…
By Tatum Anderson for Intellectual Property Watch As Indian lawyers for Swiss pharmaceutical firm Novartis comb through a High Court judgment published today, the question of whether the Indian patent law is compliant with a World Trade Organization treaty remains…
By Tatum Anderson for Intellectual Property Watch Some of the biggest names in the mobile phone industry have joined forces to share intellectual property but have stopped short of establishing the mobile industry’s first patent cooperative, known as a patent…
By Tatum Anderson for Intellectual Property Watch
A patent infringement case brought by US technology firm Qualcomm against Finnish mobile phone manufacturer Nokia at the US-based International Trade Commission (ITC) has been reinvigorated, with a hearing scheduled for 10 September.
By Tatum Anderson for Intellectual Property Watch
A debate over how long to give exclusive rights over data submitted by pharmaceutical companies to governments in order to receive approval to sell a drug in their markets is controversial not only in India, but worldwide.
By Tatum Anderson for Intellectual Property Watch
When the Indian government published its report recently on yet another pharmaceutical patent-related issue predicted to split the industry, the Indian newspapers were divided as to whether brand name producers, generics producers or public health advocates had won.
The reason for the confusion is that the report is an exercise in appeasement, said Shamnad Basheer, a law professor at George Washington University Law School, and expert on this latest controversial subject, called data exclusivity, which is the rights drugs producers have over the data used to obtain marketing approval in a country.
By Tatum Anderson for Intellectual Property Watch The latest chapter in the Swiss pharmaceutical company Novartis’ challenge to the Indian intellectual property system begins on 18 June when the Indian Patent and Trademark Appellate Board (IPAB) is scheduled to hold…
By Tatum Anderson for Intellectual Property Watch
US technology firm Qualcomm this week raised the spectre that if Finnish mobile phone manufacturer Nokia does not comply with demands within four months, a long-running worldwide intellectual property dispute between the two companies could potentially escalate. But so far, Nokia has stated its position and shows no sign of moving.
For now, the expected patent war between Qualcomm and Nokia has been delayed. Industry observers had expected Qualcomm to bring a slew of costly suits against Nokia in April for allegedly infringing its extensive patent portfolio. A patent war would pitch two of the largest mobile technology companies in the world against each other, which could have an impact on worldwide consumers' access to mobile technology products.